CRP and non-small cell lung carcinoma: In non-small cell lung cancer, the abundance of CD163+ TAMs was associated with the tumor stage, invasive size and differentiation, proliferation rate, and the presence of lymph node metastases, with C-reactive protein (CRP) levels being used as a serum marker.